KR20020033093A - 위암 위험의 예측 방법 및/또는 위암의 진단 방법 - Google Patents

위암 위험의 예측 방법 및/또는 위암의 진단 방법 Download PDF

Info

Publication number
KR20020033093A
KR20020033093A KR1020017014533A KR20017014533A KR20020033093A KR 20020033093 A KR20020033093 A KR 20020033093A KR 1020017014533 A KR1020017014533 A KR 1020017014533A KR 20017014533 A KR20017014533 A KR 20017014533A KR 20020033093 A KR20020033093 A KR 20020033093A
Authority
KR
South Korea
Prior art keywords
helicobacter
γifn
antibody
gastric cancer
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020017014533A
Other languages
English (en)
Korean (ko)
Inventor
클랜시로버트릴웰린
팡제랄드
Original Assignee
온코 얼러트 피티와이 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 온코 얼러트 피티와이 리미티드 filed Critical 온코 얼러트 피티와이 리미티드
Publication of KR20020033093A publication Critical patent/KR20020033093A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5753—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the stomach or small intestine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/54—Interleukins [IL]
    • G01N2333/5406—IL-4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
KR1020017014533A 1999-05-14 2000-05-15 위암 위험의 예측 방법 및/또는 위암의 진단 방법 Withdrawn KR20020033093A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPQ0377 1999-05-14
AUPQ0377A AUPQ037799A0 (en) 1999-05-14 1999-05-14 Methods for diagnosing and/or predicting the risk of gastric cancer
PCT/AU2000/000441 WO2000070348A1 (en) 1999-05-14 2000-05-15 Methods for predicting and/or diagnosing the risk of gastric cancer

Publications (1)

Publication Number Publication Date
KR20020033093A true KR20020033093A (ko) 2002-05-04

Family

ID=3814581

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017014533A Withdrawn KR20020033093A (ko) 1999-05-14 2000-05-15 위암 위험의 예측 방법 및/또는 위암의 진단 방법

Country Status (10)

Country Link
EP (1) EP1183540A4 (pt)
JP (1) JP2002544520A (pt)
KR (1) KR20020033093A (pt)
CN (1) CN1355885A (pt)
AU (1) AUPQ037799A0 (pt)
BR (1) BR0010558A (pt)
CA (1) CA2372761A1 (pt)
HK (1) HK1044988A1 (pt)
MX (1) MXPA01011721A (pt)
WO (1) WO2000070348A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ854100A0 (en) * 2000-07-03 2000-07-27 Helirad Pty Ltd Methods for monitoring treatment of helicobacter infection
GB2430031A (en) * 2005-09-07 2007-03-14 Ethicon Inc Diagnostic markers of wound infection
JP2014530350A (ja) * 2011-09-14 2014-11-17 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 腎臓毒性を評価するための手段及び方法
JP6707248B2 (ja) * 2013-12-05 2020-06-10 学校法人北里研究所 胃癌細胞の検出方法、及び胃癌細胞検出キット
RU2706118C1 (ru) * 2019-04-30 2019-11-14 Федеральное государственное бюджетное образовательное учреждение высшего образования "Национальный исследовательский Мордовский государственный университет им. Н.П. Огарёва" Способ прогнозирования предраковых заболеваний желудка
CN115537465A (zh) * 2022-02-28 2022-12-30 陈芳芳 Sctag在胃癌癌前预警和靶向药物中的应用
CN117143234B (zh) * 2023-08-29 2024-05-03 武汉爱博泰克生物科技有限公司 抗大鼠白细胞介素-4蛋白的单克隆抗体及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012965A1 (en) * 1994-10-20 1996-05-02 Genelabs Diagnostics Pte Ltd. Helicobacter pylori diagnostic methods and kits
IT1289578B1 (it) * 1996-12-06 1998-10-15 Sanitaria Scaligera Spa Immunopurificazione di un antigene dall'apparente peso molecolare di 16 +- 2 kda dell' helicobacter pylori e metodi per la sua

Also Published As

Publication number Publication date
WO2000070348A1 (en) 2000-11-23
HK1044988A1 (zh) 2002-11-08
EP1183540A1 (en) 2002-03-06
MXPA01011721A (es) 2003-09-10
JP2002544520A (ja) 2002-12-24
AUPQ037799A0 (en) 1999-06-10
CN1355885A (zh) 2002-06-26
EP1183540A4 (en) 2007-07-04
BR0010558A (pt) 2002-02-19
CA2372761A1 (en) 2000-11-23

Similar Documents

Publication Publication Date Title
Wolff et al. Monitoring antibody response following SARS-CoV-2 infection: diagnostic efficiency of 4 automated immunoassays
Barros et al. Gingival crevicular fluid as a source of biomarkers for periodontitis
CN102625915B (zh) 糖蛋白的测定方法、试剂及糖链标记物
Burgess et al. The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis
JP4621268B2 (ja) 癌発生及び転移に関与するタンパク質の糖鎖変化を測定して癌を診断する方法及びそれを利用した診断キット
RU2225615C2 (ru) Способ дифференциации между наличием риска образования язвы желудка и язвы двенадцатиперстной кишки
US20120115174A1 (en) Urinary trypsin inhibitors as diagnostic aid for interstitial cystitis
EP2460007A1 (en) Serum markers predicting clinical response to anti-tnfalpha antibodies in patients with psoriatic arthritis
JP2010540948A (ja) 免疫に関連した輸血反応のための予測試験およびモニタリング試験としての、サイトカインｂリンパ球刺激因子（ｂｌｙｓ）の血清学的なアッセイの使用
CN110850096B (zh) 生物标记物组及其应用和蛋白芯片、蛋白芯片试剂盒和elisa试剂盒
Jekarl et al. Evaluation of a newly developed rapid stool antigen test using an immunochromatographic assay to detect Helicobacter pylori
KR20020033093A (ko) 위암 위험의 예측 방법 및/또는 위암의 진단 방법
US20200378966A1 (en) Multiplexed assay kits for evaluation of systemic lupus erythematosus
US20040157277A1 (en) Methods for predicting and/or diagnosing the risk of gastric cancer
RU2009507C1 (ru) Способ диагностики пилорического геликобактериоза
AU4386200A (en) Methods for predicting and/or diagnosing the risk of gastric cancer
RU2137137C1 (ru) Способ определения m.leprae у больных с регрессом заболевания
AU2004242535A1 (en) Methods for predicting and/or diagnosing the risk of gastric cancer
RU2572717C1 (ru) Способ иммунодиагностики заболеваний, вызванных helicobacter pylori-инфекцией
AU2021105747A4 (en) Application of diagnostic kit and MAK16 in preparation of reagent for early diagnosis of systemic lupus erythematosus
RU2141667C1 (ru) Способ диагностики эрозивного гастродуоденита и язвенной болезни у детей
RU2236012C1 (ru) Способ прогноза осложненного течения демодекозного блефароконъюнктивита
Chen et al. Circulating immune cell phenotypes are associated with inflammatory biomarkers in dementia-free participants from the Framingham Heart Study Offspring cohort
WO2002035233A1 (en) Cytokine capture assay methods and uses
Chakawa Immuno-epidemiology of helicobacter pylori-associated autoimmune conditions in Zimbabwean patients.

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

N231 Notification of change of applicant
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203

WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid
P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000